ArticleJournal of experimental orthopaedics2026
Multimodal evaluation of periosteal versus collagen membrane coverage in atelocollagen-associated autologous chondrocyte implantation for large knee cartilage defects.
Article in Journal of experimental orthopaedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Atelocollagen-associated autologous chondrocyte implantation (A-ACI) with periosteal coverage shows favourable outcomes for large knee cartilage defects but is associated with complications such as graft hypertrophy. Collagen membrane coverage remains under-investigated in this technique. This study aimed to evaluate periosteal versus collagen membrane coverage using clinical, radiological, arthroscopic and histological assessments. Methods: Between 2014 and 2022, patients with ≥4.0 cm Results: Both groups demonstrated significant clinical improvement at 24 months without significant between-group differences. MOCART 2.0 scores were significantly higher in the collagen membrane group at 12 and 24 months (83 vs. 60 at 24 months, Conclusions: The primary clinical outcomes improved similarly in both groups at two years without meaningful between-group superiority. While collagen membrane coverage was associated with higher MOCART 2.0 scores after adjustment for concomitant osteotomy, all structural evaluations should be regarded strictly as secondary and exploratory. Level of Evidence: Level III.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.